ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Nexalin Technologies Inc

Nexalin Technologies Inc (NXL)

0.8992
-0.4811
(-34.85%)
Closed June 15 4:00PM
0.7911
-0.1081
(-12.02%)
After Hours: 7:59PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.7911
Bid
0.8079
Ask
0.838
Volume
3,929,536
0.801 Day's Range 1.45
0.2528 52 Week Range 3.40
Market Cap
Previous Close
1.3803
Open
1.01
Last Trade Time
Financial Volume
$ 3,785,287
VWAP
0.963291
Average Volume (3m)
739,000
Shares Outstanding
7,436,562
Dividend Yield
-
PE Ratio
-1.42
Earnings Per Share (EPS)
-0.63
Revenue
111k
Net Profit
-4.65M

About Nexalin Technologies Inc

Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic.

Sector
Electromedical Apparatus
Industry
Electromedical Apparatus
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Nexalin Technologies Inc is listed in the Electromedical Apparatus sector of the NASDAQ with ticker NXL. The last closing price for Nexalin Technologies was $1.38. Over the last year, Nexalin Technologies shares have traded in a share price range of $ 0.2528 to $ 3.40.

Nexalin Technologies currently has 7,436,562 shares outstanding. The market capitalization of Nexalin Technologies is $6.62 million. Nexalin Technologies has a price to earnings ratio (PE ratio) of -1.42.

NXL Latest News

Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)

HOUSTON, TX, June 13, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that its second generation (Gen-2), 15 milliamp (mA...

Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th

HOUSTON, TX, June 04, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced today that it will be participating in the Spring MicroCap...

FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset Device

HOUSTON, TX, June 03, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announces that the U.S. Food and Drug Administration (FDA) has provided...

Nexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research Efforts

HOUSTON, TX, May 22, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to announce its new division, Nexalin America, has been...

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on May 23

HOUSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to invite investors to a webinar on May 23, 2024, at 4:15 p.m. ET...

Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements

HOUSTON, TEXAS, April 25, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced that the Company received notice from The Nasdaq Stock...

Nexalin Technology Accelerates Manufacturing of its HALO™ Clarity Following Successful Usability, Feasibility, and Electrical Testing

The new Gen-3 HALO™ Clarity 15 milliamp (mA) HOUSTON, TX, April 09, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced it has...

Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device

HOUSTON, TX, April 04, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office...

Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board

HOUSTON, TEXAS, April 02, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW), today announced the appointment of former Acting General Counsel to...

Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego

Collaborative Study involving the VA and UCSD achieved statistically significant decrease in PCS and PTSD symptoms versus control group The data supports the Company’s strategy to offer military...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.081111.42253521130.711.50.5317877871.36766689CS
4-0.5489-40.96268656721.341.50.535067081.32901206CS
120.321168.31914893620.473.40.45517390001.83393905CS
260.3451577.39656912210.445953.40.25285023841.41194226CS
52-0.0852-9.722697706260.87633.40.25282700051.34000813CS
156-1.9089-70.72.73.40.25282180061.37455048CS
260-1.9089-70.72.73.40.25282180061.37455048CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 5.96
(338.24%)
70.99M
LRHCLa Rosa Holdings Corporation
$ 1.165
(90.61%)
40.6M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
BRFHBarfresh Food Group Inc
$ 3.03
(38.36%)
247.31k
NNENano Nuclear Energy Inc
$ 9.37
(32.53%)
1.77M
NXLNexalin Technologies Inc
$ 0.89
(-35.52%)
3.93M
INABIN8bio Inc
$ 1.095
(-34.82%)
4.92M
QXOQXO Inc
$ 134.10
(-34.71%)
142.29k
GANXGain Therapeutics Inc
$ 1.24
(-34.39%)
3.09M
KYTXKyverna Therapeutics Inc
$ 9.52
(-34.07%)
4.31M
NVDANVIDIA Corporation
$ 131.88
(1.75%)
309.34M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
KITTNauticus Robotics Inc
$ 0.1921
(19.69%)
165.83M
CRKNCrown Electrokinetics Corporation
$ 0.0582
(-21.35%)
136.77M
SQQQProShares UltraPro Short QQQ
$ 8.43
(-1.29%)
112.46M

NXL Discussion

View Posts
GhosTraderX GhosTraderX 1 day ago
Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)

Source: GlobeNewswire Inc.?

Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that its second generation (Gen-2), 15 milliamp (mA) neurostimulation device has been granted regulatory approval by the Brazilian Health Regulatory Agency, a regulatory body of the Brazilian government responsible for approving new drugs and medical devices.
Mark White, CEO of Nexalin Technology, stated, "We are pleased to announce approval to sell our Gen-2 neurostimulation device in Brazil, which represents our second regulatory approval outside of China since the start of this year.  Brazil is an important market as it represents the 9th largest economy in the world with a population in excess of 215 million.  Among this population, more than 35 million are afflicted with mental health disorders. Moreover, this approval is an important springboard into other markets within South America.  We are rapidly advancing discussions with a key distributor in this market and look forward to providing further updates.”
About Nexalin Technology, Inc.
Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic. All of Nexalin’s products are believed to be non-invasive and undetectable to the human body and are developed to provide relief to those afflicted with mental health issues. Nexalin utilizes bioelectronic medical technology to treat mental health issues. Nexalin believes its neurostimulation medical devices can penetrate structures deep in the mid-brain that are associated with mental health disorders. Nexalin believes the deeper-penetrating waveform in its next-generation devices will generate enhanced patient response without any adverse side effects. The Nexalin Gen-2 15 milliamp neurostimulation device was recently approved in Oman and China.  Additional information about the Company is available at: https://nexalin.com/.
FORWARD-LOOKING STATEMENTS

This press release contains statements that constitute "forward-looking statements," These statements relate to future events or Nexalin’s future financial performance. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements to the effect that Nexalin or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward looking statements that involve risks and uncertainties which could cause actual events or Nexalin’s actual results to differ materially from those indicated by the forward-looking statements.  Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's Report on Form 10-K for the year ended December 31, 2023 and other filings as filed with the Securities and Exchange Commission. Copies of such filings are available on the SEC's website, www.sec.gov. Such forward-looking statements are made as of the date hereof and may become outdated over time. Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Contact:
Crescendo Communications, LLC
Tel: (212) 671-1020
Email: NXL@crescendo-ir.com
Dave Gentry, CEO
RedChip Companies Inc.
407-491-4498
NXL@redchip.com
👍️0
Awl416 Awl416 2 months ago
Yikes
👍️0
bikaver bikaver 2 months ago
NXL...grabbed a few @ 2.38
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
lol
👍️0
Invest-in-America Invest-in-America 2 months ago
NXL: I do get in my CLOWN moods, occasionally. (Right now, I have to CHANGE my iHub Profile Picture --- to reflect my TRUE inner spirit!!!)
👍️0
Invest-in-America Invest-in-America 2 months ago
NXL: HA-HAAAAA!!! Why not???
👍️0
Invest-in-America Invest-in-America 2 months ago
NXL: Hey, and THANKS again for the selfie video clip of YOU (below), working your latest "AI-MARKETS-SCANNER"!!!


"I see a price CORRECTION looming in precisely 15-seconds on NXL --- prepare to abort the play!!! And reload to FLIP-IT again!!!"
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
I MAY NEED TO USE ONE OF THEIR HEAD BANDS FOR TAKING THIS OFF MY SCREEN
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
LOL..YOU MAKE ME LAUGH DUDE
👍️0
Invest-in-America Invest-in-America 2 months ago
NXL: Hey, Dude, I FOLLOW your posts everyday --- like a Police Dog on a short leash!!!
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
MARKET CORRECTION IS HERE
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
LMAO...LUV YOU DUDE...CAN'T BELIEVE I WAS THE FIRST HERE AND FIRST TO GO....IDIOT I AM!
👍️0
Invest-in-America Invest-in-America 2 months ago
NXL: Hey there, Lord T-T-2016, Dude!!! What-the-fluck is goin' on today, Homeboy --- across the Wall Street MARKETOS!!!

PS: The LEAD GUITAR RIFT in that Pat Benetar song is OFF-THE-SPECTRUM, Bro!! That guitar dude hits a NOTE therein that is from another GALAXY!!!


(Let the above run, until that LEAD GUITAR does his stuff!!!)
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
LMAO...FLEET COMANDO!!!!
👍️0
Invest-in-America Invest-in-America 2 months ago
NXL: This is the Fleet Commander to all NXL Company warships --- FIRE-AT-WILL!!!



👍️0
Invest-in-America Invest-in-America 2 months ago
Nope, that monster number there was NOT me dumping my @VVPR --- but that WAS an easy & quick flip, for my little (late Pre-M) 'Lotto Ticket' behind it.
👍️0
TIMGZ TIMGZ 2 months ago
VVPR
👍️0
Invest-in-America Invest-in-America 2 months ago
Not sure WHICH stock you are referring to, Capt. TIm.
👍️0
TIMGZ TIMGZ 2 months ago
2M FLOAT,LOOK AT THE BIG DUMP***18M ONE TIME, THATMUSTBEYOU
👍️0
Invest-in-America Invest-in-America 2 months ago
@AINC merely the old ploy, 'We ain't gonna dump more shares on ya, America, so make our stock SOAR now!!' (And @VVPR a nice quip FLIP, right out the starting gate today, Dude!!!)
👍️0
TIMGZ TIMGZ 2 months ago
ADTX,VVPR, AINC e.t.c
👍️0
Invest-in-America Invest-in-America 2 months ago
NXL: Told ya so!!!! To dah MOON!!!
👍️0
Invest-in-America Invest-in-America 2 months ago
NXL: Watch out!! They gots some BONKERS Electromagnetic GADGETS at the NXL Firm!!! (See ME, below, using one their disruptive new "Post-Traumatic-STUPIDITY-Disorder", deep-Brain, stimulators during routine brushing of my teeth!!!)

👍️0
Bigspirit1 Bigspirit1 3 months ago
you were right
👍️0
realtmg realtmg 3 months ago
Closed up 50% … Expecting continuation going north tomorrow… IMO
👍️0
Bigspirit1 Bigspirit1 3 months ago
A real micro beast. The product pipeline is amazing!
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
NXL..THIN....HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
NXL...HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
NXL...BLOWING UP
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
NXL...MICRO BEAST
👍️0
realtmg realtmg 3 months ago
Nice news… Took a position
👍️0
Awl416 Awl416 6 months ago
Nexalin Technology Reports Significant Positive Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device on Treatment-Resistant Depression
👍️0
Awl416 Awl416 8 months ago
Nexalin Technology Announces Publication of Groundbreaking Deep-Brain Stimulation Study in Leading Peer-Reviewed Journal; Validates the Ability of Nexalin’s Neurostimulation Device to Penetrate Deep Brain Structures
👍️0
Bigspirit1 Bigspirit1 11 months ago
Agreed
👍️ 1
SittingPretty SittingPretty 11 months ago
Nexalin Technology Announces Abstract Accepted for Presentation at 2023 Military Health System Research Symposium Validating the Potential of its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device
👍️0
SittingPretty SittingPretty 11 months ago
lol NXL gonna be! Grabbed more today off the bid sweet spot!
👍️0
Bigspirit1 Bigspirit1 11 months ago
Wassup sitting pretty?
👍️0
SittingPretty SittingPretty 11 months ago
She's getting ready
👍️0
Bigspirit1 Bigspirit1 2 years ago
NXL has an impressive clinical pipeline!
👍️0

Your Recent History

Delayed Upgrade Clock